HCPCS Level II code J7500 denotes azathioprine, oral, 50 mg, an oral immunosuppressant used in autoimmune disease management and transplant medicine. This code matters nationally because it standardizes billing for a widely prescribed systemic medication with implications for pharmacy reimbursement, payer coverage policies, and outpatient medication management.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for azathioprine use, typical sites of service for billing (outpatient pharmacy, clinic dispensing), and the practical billing considerations tied to HCPCS Level II coding. The publication outlines common modifiers associated with HCPCS drug administration and dispensing (listed separately), and summarizes how payers commonly approach coverage and prior authorization for oral immunosuppressants.

This resource provides benchmarks for billing practice, notes on policy updates affecting HCPCS Level II drug codes, and concise clinical context to help billing teams and policy analysts understand where J7500 fits into outpatient pharmacy workflows and payer coverage frameworks. Data not available in the input is identified explicitly where applicable.